Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 7/2019

Ausgabe 7/2019

Inhaltsverzeichnis ( 15 Artikel )

05.06.2019 | Review | Ausgabe 7/2019

PLAC1: biology and potential application in cancer immunotherapy

Jafar Mahmoudian, Roya Ghods, Mahboobeh Nazari, Mahmood Jeddi-Tehrani, Mohammad Hossein Ghahremani, Nassim Ghaffari-Tabrizi-Wizsy, Seyed Nasser Ostad, Amir-Hassan Zarnani

10.04.2019 | Original Article | Ausgabe 7/2019 Open Access

Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma

Shuo Liu, Zhen Han, Anna L. Trivett, Hongsheng Lin, Sean Hannifin, De Yang, Joost J. Oppenheim

03.06.2019 | Original Article | Ausgabe 7/2019 Open Access

Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses

Zhen Han, Shuo Liu, Hongsheng Lin, Anna L. Trivett, Sean Hannifin, De Yang, Joost J. Oppenheim

14.05.2019 | Original Article | Ausgabe 7/2019 Open Access

Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

Yen-Lin Chen, Wen-Chien Huang, Feng-Ming Lin, Huangpin B. Hsieh, Chia-Hsun Hsieh, Ruey Kuen Hsieh, Kuo-Wei Chen, Ming-Hong Yen, James Lee, Stephen Su, Twinkal Marfatia, Shih-En Chang, Padma Sundar, Bruce Patterson, Drew Watson, Rui Mei, Manana Javey

18.05.2019 | Original Article | Ausgabe 7/2019

Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Lindsey M. Kuehm, Kyle Wolf, John Zahour, Richard J. DiPaolo, Ryan M. Teague

22.05.2019 | Original Article | Ausgabe 7/2019

Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma

Pravin Kesarwani, Antony Prabhu, Shiva Kant, Prakash Chinnaiyan

27.05.2019 | Original Article | Ausgabe 7/2019

Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors

Katie M. Leick, Joel Pinczewski, Ileana S. Mauldin, Samuel J. Young, Donna H. Deacon, Amber N. Woods, Marcus W. Bosenberg, Victor H. Engelhard, Craig L. Slingluff Jr.

28.05.2019 | Original Article | Ausgabe 7/2019

Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma

Sonja Ludwig, Chang-Sook Hong, Beatrice M. Razzo, Kellsye P. L. Fabian, Manoj Chelvanambi, Stephan Lang, Walter J. Storkus, Theresa L. Whiteside

08.06.2019 | Original Article | Ausgabe 7/2019

An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice

Richard F. Jones, Joyce D. Reyes, Heather M. Gibson, Jennifer B. Jacob, Ulka Vaishampayan, Stuart Ratner, Kang Chen, Wei-Zen Wei

13.06.2019 | Original Article | Ausgabe 7/2019

Clinicopathological implications of TIM3+ tumor-infiltrating lymphocytes and the miR-455-5p/Galectin-9 axis in skull base chordoma patients

Jinpeng Zhou, Yang Jiang, Haiying Zhang, Lian Chen, Peng Luo, Long Li, Junshuang Zhao, Fei Lv, Dan Zou, Ye Zhang, Zhitao Jing

07.06.2019 | Original Article | Ausgabe 7/2019

Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma

Antoine Moya-Plana, Ruth Gabriela Herrera Gómez, Caroline Rossoni, Laurent Dercle, Samy Ammari, Isabelle Girault, Séverine Roy, Jean-Yves Scoazec, Stephan Vagner, François Janot, Alexander M. M. Eggermont, Caroline Robert

07.06.2019 | Original Article | Ausgabe 7/2019 Open Access

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Ernesto Rossi, Monica Maria Pagliara, Daniela Orteschi, Tommaso Dosa, Maria Grazia Sammarco, Carmela Grazia Caputo, Gianluigi Petrone, Guido Rindi, Marcella Zollino, Maria Antonietta Blasi, Alessandra Cassano, Emilio Bria, Giampaolo Tortora, Giovanni Schinzari

11.06.2019 | Original Article | Ausgabe 7/2019

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases

Yenny Angela, Sebastian Haferkamp, Carsten Weishaupt, Selma Ugurel, Jürgen C. Becker, Florian Oberndörfer, Vesna Alar, Imke Satzger, Ralf Gutzmer

08.06.2019 | Original Article | Ausgabe 7/2019

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Wenjie Gong, Jean-Marc Hoffmann, Sophia Stock, Lei Wang, Yibin Liu, Maria-Luisa Schubert, Brigitte Neuber, Angela Hückelhoven-Krauss, Ulrike Gern, Anita Schmitt, Carsten Müller-Tidow, Hiroshi Shiku, Michael Schmitt, Leopold Sellner

08.05.2019 | Clinical Trial Report | Ausgabe 7/2019

First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1

Amit Mahipal, Samuel Ejadi, Sacha Gnjatic, Seunghee Kim-Schulze, Hailing Lu, Jan H. ter Meulen, Richard Kenney, Kunle Odunsi

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise